Published price vs quote-only
Shed vs TMates: Which One Publishes Its Price? (2026)
Compare Shed and TMates on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Shed and TMates both prescribe GLP-1 medication online, take payment directly from the patient and ship to the door. That is where the overlap stops.
One of these programs can be evaluated before you start it and one cannot. TMates lists $199/mo at every dose, no step-up fees; with Shed, Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Anything a provider declines to disclose is marked undisclosed rather than filled in.
The short answer
- Easier to price in advance
- TMates — $199/mo at every dose, no step-up fees. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Least friction to get going
- TMates — Virtual check-in appointments, then medication formulated in U.S. facilities.
- Most support included
- Shed — Continuous coaching built into every treatment plan.
Shed vs TMates at a glance
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Shed | TMates | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | $199/mo at every dose, no step-up fees |
| Rate after promotions | not published before intake | $199/mo |
| Pricing structure | Quoted only after intake | Flat rate at every dose |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide |
| Price transparency | Quote only, after intake | Published upfront |
| State coverage | Not published | All 50 states |
| How fast you start | 2-minute approval assessment | Virtual check-in appointments |
| Membership fee | Not stated | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 8,500 | 21,970 |
| eRxDoctor score | 9.9/10 | 7.0/10 |
The real cost: six months and twelve
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Shed | TMates | |
|---|---|---|
| First month | Not published | $199 |
| Months 2 onward | Not published | $199/mo |
| 6-month total | Not computable | $1,194 |
| 12-month total | Not computable | $2,388 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
One publishes a price. One does not.
With TMates the arithmetic is available in advance — $199/mo at every dose, no step-up fees, on flat rate at every dose terms — so it can be compared against anything else on the market.
Shed withholds the figure until 2-minute approval assessment is complete — Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Whatever the reason, it moves the price conversation to after your commitment rather than before it.
Treat Shed's quote as the start of the comparison rather than the end of it, and check specifically what happens to the number at higher doses.
A closer look at Shed
Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month. Against TMates, that puts it in the position of the harder of the two to price in advance.
Intake is 2-minute approval assessment. Fulfillment is home delivery after clinician review. The commercial terms are quoted only after intake, quote only, after intake.
What continues after the first shipment: continuous coaching built into every treatment plan. Formulary: name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
- 10% off your first month for new patients
- Fast 2-minute approval assessment
- Flexibility to choose medication type based on budget and needs
Shed cons
- Standard pricing is not published, you receive a personalized quote after intake
- Coaching-bundled model can cost more than bare-prescription platforms
- Name-brand options carry significantly higher costs than compounded alternatives
Read next to TMates, the weak point: you cannot know what you will pay until you have finished the intake.
TMates: what you are buying
$199/month, every dose, no step-up fees What it is really selling here is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
Practically: virtual check-in appointments, medication formulated in U.S. facilities, and a pricing model that is flat rate at every dose.
24/7 access to U.S.-based doctors, not just messaging. The formulary covers compounded semaglutide.
TMates pros
- Virtual check-in appointments for ongoing medical oversight
- Flat $199/month at every dose, no step-up fees as dosage escalates
- 24/7 access to U.S.-based doctors, not just messaging support
- Licensed coverage in all 50 states
TMates cons
- Compounded semaglutide only, limited public detail on tirzepatide availability
- $199/month is higher than the cheapest compounded options
- No branded Ozempic, Wegovy, or Zepbound
The reservation worth holding, particularly next to Shed: semaglutide only, and $199 is well above the cheapest compounded options.
Who should choose Shed, and who should choose TMates
Choose Shed if:
- you want continuous coaching built into every treatment plan rather than a prescription alone
- you want an FDA-approved finished medication rather than a compounded preparation
- the level of clinical contact suits you: continuous coaching built into every treatment plan
- you would get real value from one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
Choose TMates if:
- you want to start on their timeline: virtual check-in appointments
- the level of clinical contact suits you: 24/7 access to U.S.-based doctors, not just messaging
- delivery works the way you want it to: medication formulated in U.S. facilities
- you are in a state where GLP-1 telehealth coverage is patchy
Honest trade-offs
On price. Only TMates publishes a rate you can plan against ($199/mo at every dose, no step-up fees). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On predictability. The pricing structures differ (quoted only after intake versus flat rate at every dose), and structure, not headline rate, determines the twelve-month bill.
On access. Shed advertises 2-minute approval assessment and home delivery after clinician review; TMates advertises virtual check-in appointments and medication formulated in U.S. facilities. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
Evidence and regulatory status
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
In the STEP 1 trial, weekly semaglutide 2.4 mg produced a mean body-weight change of −14.9% at 68 weeks against −2.4% on placebo, per NEJM, STEP 1.
The STEP 1 extension found participants regained roughly two-thirds of the weight they had lost within a year of stopping semaglutide, per Diabetes, Obesity and Metabolism.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Shed vs TMates: common questions
Is coaching included with Shed or TMates?
Shed includes continuous coaching built into every treatment plan in the monthly price. TMates provides 24/7 access to U.S.-based doctors, not just messaging, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
Can I switch from Shed to TMates later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge.
Do Shed and TMates prescribe the same medication?
No. Shed dispenses both name-brand FDA-approved medication and compounded alternatives; TMates dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
What happens if I stop taking the medication?
Neither Shed nor TMates penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Is Shed or TMates better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Shed has the stronger case; after month three, cost should take over.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; TMates leads on one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Shed vs NoviPublished price vs quote-only
- Shed vs LIV BodyPublished price vs quote-only
- Gala vs TMatesLarge platform vs smaller platform
- Refills vs TMatesBudget vs premium
- TrimRx vs DirectmedsPublished price vs quote-only
- TrimRx vs WellorithmPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or TMates, and does not sell treatment. Read our ranking methodology.